With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market growth in the ...

Medtronic — the world's largest medical device company — is preparing for potential new import taxes and other policy changes ...

CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues ...

Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...

Medtronic has reported revenue gains across several of its medical device franchises, leading the company to ... aortic valve ...

Although some of the trial’s methodology was critiqued, the results provide fodder for shared decision-making discussions.

Boston Scientific, Medtronic and J&J are moving quickly to secure their place in the fast-growing pulsed field ablation space ...

Boston Scientific (BSX) stock climbed 5% after a study showed its Watchman FLX device was superior to oral anti-coagulants in reducing bleeding risks following cardiac ablation.

Left atrial appendage closure is an alternative strategy for stroke prophylaxis, Wazni and colleagues noted. "The safety and ...

Marie Thibault, an analyst from BTIG, maintained the Buy rating on Boston Scientific (BSX – Research Report). The associated price target ...

Boston Scientific announced positive three-year primary endpoint results from a clinical trial of its Watchman FLX device.